[at noodls] – Risa Stack Announces Planned Departure From the Trius Board SAN DIEGO, April 3, 2013 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today the appointment of Seth H. Z. Fischer to … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboardSee who Trius is hiring next, click here to […]
[at noodls] – SAN DIEGO, April 2, 2013 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will provide … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboardSee who Trius is hiring next, click here to view […]
[at noodls] – SAN DIEGO, Feb. 12, 2013 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery and development of innovative antibiotics for serious infections, … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboardSee who Trius is hiring next, click here to view […]
[at noodls] – SAN DIEGO, Jan. 18, 2013 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced the pricing of an underwritten public offering of 6,300,000 shares of its common stock at a price to … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboardSee who Trius is hiring next, click here […]
[at noodls] – SAN DIEGO, Jan. 17, 2013 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Citigroup … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboardSee who Trius is hiring next, click here […]
[at noodls] – FDA’s Action Expedites Regulatory Review Process of the New Drug Application (NDA) SAN DIEGO, Jan. 7, 2013 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboardSee who Trius is hiring next, click here to view […]
[at noodls] – SAN DIEGO, Dec. 10, 2012 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery and development of innovative antibiotics for life-threatening … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboardSee who Trius is hiring next, click here to view […]
[at noodls] – SAN DIEGO, Nov. 14, 2012 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – SAN DIEGO, Nov. 12, 2012 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will provide … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jason Napodano, CFAFundamentals at Trius Therapeutics (NASDAQ:TSRX) remain solid. I see the development of tedizolid, current in its second phase 3 trial, as low risk. Data from the first phase 3 trial … moreView todays social media effects on TSRXView the latest stocks trending across Twitter. Click to view dashboard […]
